ESR1 and breast carcinoma: Based on a phase II study performed in patients with advanced breast cancer, published in 1976, the investigators concluded: “a high degree of correlation between response and positive estrogen-receptor assay suggests the value of the diagnostic test as a means to select patients for tamoxifen treatment” (1).